| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CD14 molecule | 0.392 | 0.885 | 4.9E-05 |
|
phenotype | 0.230 | None | 0.750 | 1 | 0 | 2002 | 2019 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
phenotype | 0.250 | None | 0.833 | 1 | 0 | 1999 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.300 | None | 0.929 | 1 | 0 | 1999 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.300 | None | 0.935 | 3 | 0 | 1996 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.300 | None | 0.956 | 6 | 0 | 1994 | 2019 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
phenotype | 0.200 | None | 1.000 | 4 | 0 | 2010 | 2015 | ||||||||
|
serpin family C member 1 | 0.507 | 0.769 | 1.00 |
|
phenotype | 0.210 | None | 1.000 | 3 | 0 | 2005 | 2017 | ||||||||
|
thromboxane A2 receptor | 0.597 | 0.654 | 1.3E-04 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 1985 | 2005 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
phenotype | 0.540 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
phosphoenolpyruvate carboxykinase 1 | 0.608 | 0.538 | 8.7E-15 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2002 | 2009 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
phenotype | 0.240 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
growth hormone receptor | 0.490 | 0.846 | 8.4E-05 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2002 | 2002 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
phenotype | 0.210 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
activating transcription factor 2 | 0.551 | 0.808 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.220 | None | 1.000 | 2 | 0 | 2002 | 2020 | ||||||||
|
prostaglandin E receptor 4 | 0.558 | 0.731 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
C-X3-C motif chemokine ligand 1 | 0.478 | 0.808 | 0.61 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2011 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2013 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.240 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1999 | 2020 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
phosphoenolpyruvate carboxykinase 2, mitochondrial | 0.653 | 0.423 | 1.7E-23 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 |